Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis by Mads Svart, Nikolaj Rittig, Niels Møller, Holger J Møller, Henning Gronbaek

Get full text

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial by Nikolaj Rittig, Mads Svart, Niels Jessen, Niels Møller, Holger J Møller, Henning Grønbæk

Get full text

Human Adipose Tissue Macrophages Are Enhanced but Changed to an Anti-Inflammatory Profile in Obesity by Karen Fjeldborg, Steen B. Pedersen, Holger J. Møller, Tore Christiansen, Marianne Bennetzen, Bjørn Richelsen

Get full text

A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRPα) by Yoanna V. Vladimirova, Marie K. Mølmer, Kristian W. Antonsen, Niels Møller, Nikolaj Rittig, Marlene C. Nielsen, Holger J. Møller

Get full text

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes by Pia Svendsen, Jonas H. Graversen, Anders Etzerodt, Henrik Hager, Rasmus Røge, Henning Grønbæk, Erik I. Christensen, Holger J. Møller, Hendrik Vilstrup, Søren K. Moestrup

Get full text

The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of t... by Greet De Vlieger, Ilse Vanhorebeek, Pieter J. Wouters, Inge Derese, Michael P. Casaer, Yves Debaveye, Greet Hermans, Philippe Meersseman, Holger J. Møller, Greet Van den Berghe, Catherine Ingels

Get full text

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma by Heli Vajavaara, Frida Ekeblad, Harald Holte, Judit Jorgensen, Suvi-Katri Leivonen, Mattias Berglund, Peter Kamper, Holger J. Moller, Francesco d’Amore, Daniel Molin, Gunilla Enblad, Maja Ludvigsen, Ingrid Glimelius, Sirpa Leppa

Get full text